NASDAQ · Biotechnology
Acurx Pharmaceuticals LLC (ACXP)
$1.04
+0.97%
45
In band
Moving averages
SMA 200$1.92-45.83%
Company profile
Acurx Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company is headquartered in Staten Island, New York.
SectorHealthcare
IndustryBiotechnology
Market cap$5.64M
P/E ratioNone
EPS$-2.67
Beta-2.085
Dividend yield0.00%
52-week high$7.54
52-week low$0.95
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
SKYE
Skye Bioscience Inc
RSI 32
SNGX
Soligenix Inc
RSI 21
IMNN
Imunon Inc
RSI 25
PHIO
Phio Pharmaceuticals Corp
RSI 28
BCDA
BioCardia Inc
RSI 34
KTTA
Pasithea Therapeutics Corp
RSI 53
RSI alerts for ACXP
An email when ACXP closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 5:39 AM EST